Doorgaan naar hoofdcontent

Human medicines European public assessment report (EPAR): Nexviadyme, Avalglucosidase alfa, Glycogen Storage Disease ...

Human medicines European public assessment report (EPAR): Nexviadyme, Avalglucosidase alfa, Glycogen Storage Disease Type II, Date of authorisation: 24/06/2022, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Nexviadyme, Avalglucosidase alfa, Glycogen Storage Disease Type II, Date of authorisation: 24/06/2022, Revision: 1, Status: Authorised
 
Wil je het laatste nieuws in jouw mailbox ontvangen?
Meld je dan aan voor de nieuwsbrief.